Insider · CIK 0001227124

GODDARD PAUL

Reports to the SEC for 7 companies · FREMONT, CA

sec.gov

Transactions

Companies

Filings

CIK

0001227124

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2018-11-27	Corium International, Inc.Director Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−20K sh	$12.50	−$250K	0
2018-11-27	Corium International, Inc.Director Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−15K sh	$12.50	−$188K	0
2018-11-27	Corium International, Inc.Director Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−12K sh	$12.50	−$150K	0
2018-11-27	Corium International, Inc.Director Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−15K sh	$12.50	−$188K	0
2017-12-01	Corium International, Inc.Director Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2016-12-22	Corium International, Inc.Director Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2015-12-18	Corium International, Inc.Director Stock Option (right to buy)A Award	Director	AAward	+12K sh	—	—	12,000
2014-12-04	Corium International, Inc.Director Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2013-10-01	ONYX PHARMACEUTICALS INCStock OptionsD Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	—	—	0
2013-10-01	ONYX PHARMACEUTICALS INCStock OptionsD Disposition to Issuer	Director	DDisposition to Issuer	−5,900 sh	—	—	0
2013-10-01	ONYX PHARMACEUTICALS INCStock OptionsD Disposition to Issuer	Director	DDisposition to Issuer	−1,000 sh	—	—	0
2013-10-01	ONYX PHARMACEUTICALS INCD Disposition to Issuer	Director	DDisposition to Issuer	−2,100 sh	$125.00	−$263K	0
2013-10-01	ONYX PHARMACEUTICALS INCStock OptionsD Disposition to Issuer	Director	DDisposition to Issuer	−5,726 sh	—	—	0
2013-10-01	ONYX PHARMACEUTICALS INCStock OptionsD Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	—	—	0
2013-10-01	ONYX PHARMACEUTICALS INCStock OptionsD Disposition to Issuer	Director	DDisposition to Issuer	−5,000 sh	—	—	0
2013-10-01	ONYX PHARMACEUTICALS INCStock OptionsD Disposition to Issuer	Director	DDisposition to Issuer	−5,000 sh	—	—	0
2013-10-01	ONYX PHARMACEUTICALS INCU Disposition from Tender	Director	UDisposition from Tender	−12.8K sh	$125.00	−$1.6M	2,100
2013-10-01	ONYX PHARMACEUTICALS INCStock OptionsD Disposition to Issuer	Director	DDisposition to Issuer	−5,000 sh	—	—	0
2013-10-01	ONYX PHARMACEUTICALS INCStock OptionsD Disposition to Issuer	Director	DDisposition to Issuer	−2,000 sh	—	—	0
2013-07-01	ONYX PHARMACEUTICALS INCS Sale	Director	SSale	−2,500 sh	$132.63	−$332K	14,890
2013-07-01	ONYX PHARMACEUTICALS INCS Sale	Director	SSale	−3,500 sh	$131.92	−$462K	17,390
2013-07-01	ONYX PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+4,000 sh	$28.41	+$114K	20,890
2013-07-01	ONYX PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+2,000 sh	$12.50	+$25K	16,890
2013-07-01	ONYX PHARMACEUTICALS INCStock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,000 sh	—	—	0
2013-07-01	ONYX PHARMACEUTICALS INCStock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−4,000 sh	—	—	1,000
2013-05-08	ONYX PHARMACEUTICALS INCStock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−1,000 sh	—	—	5,000
2013-05-08	ONYX PHARMACEUTICALS INCS Sale	Director	SSale	−1,000 sh	$95.00	−$95K	14,890
2013-05-08	ONYX PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+1,000 sh	$28.41	+$28.4K	15,890
2013-05-01	ONYX PHARMACEUTICALS INCS Sale	Director	SSale	−1,000 sh	$93.84	−$93.8K	15,890
2013-05-01	ONYX PHARMACEUTICALS INCS Sale	Director	SSale	−800 sh	$93.02	−$74.4K	15,090
2013-05-01	ONYX PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+1,000 sh	$28.41	+$28.4K	19,890
2013-05-01	ONYX PHARMACEUTICALS INCS Sale	Director	SSale	−3,000 sh	$92.67	−$278K	16,890
2013-05-01	ONYX PHARMACEUTICALS INCS Sale	Director	SSale	−200 sh	$94.08	−$18.8K	14,890
2013-05-01	ONYX PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+4,000 sh	$12.50	+$50K	18,890
2013-05-01	ONYX PHARMACEUTICALS INCStock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−4,000 sh	—	—	2,000
2013-05-01	ONYX PHARMACEUTICALS INCStock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−1,000 sh	—	—	6,000
2013-04-10	ONYX PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+2,000 sh	$28.41	+$56.8K	16,890
2013-04-10	ONYX PHARMACEUTICALS INCS Sale	Director	SSale	−2,000 sh	$95.00	−$190K	14,890
2013-04-10	ONYX PHARMACEUTICALS INCStock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,000 sh	—	—	7,000
2013-03-28	ONYX PHARMACEUTICALS INCStock Option (Right to Buy)A Award	Director	AAward	+5,900 sh	—	—	5,900
2013-03-28	ONYX PHARMACEUTICALS INCA Award	Director	AAward	+2,100 sh	—	—	14,890
2013-03-08	ONYX PHARMACEUTICALS INCStock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−1,000 sh	—	—	9,000
2013-03-08	ONYX PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+1,000 sh	$28.41	+$28.4K	13,790
2013-03-08	ONYX PHARMACEUTICALS INCS Sale	Director	SSale	−1,000 sh	$85.00	−$85K	12,790
2013-03-01	ONYX PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+4,000 sh	$12.50	+$50K	16,790
2013-03-01	ONYX PHARMACEUTICALS INCS Sale	Director	SSale	−4,000 sh	$74.35	−$297K	12,790
2013-03-01	ONYX PHARMACEUTICALS INCStock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−4,000 sh	—	—	6,000
2013-01-09	ONYX PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+5,000 sh	$33.56	+$168K	17,790
2013-01-09	ONYX PHARMACEUTICALS INCS Sale	Director	SSale	−1,000 sh	$85.00	−$85K	12,790
2013-01-09	ONYX PHARMACEUTICALS INCStock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−5,000 sh	—	—	0

Recent filings

Accepted (ET)
Nov 284
GODDARD PAUL0001567619-18-007068
SEC(opens sec.gov)
Dec 54
GODDARD PAUL0001140361-17-045107
SEC(opens sec.gov)
Dec 274
Corium International, Inc.0001140361-16-090846
SEC(opens sec.gov)
Dec 224
Corium International, Inc.0001140361-15-045354
SEC(opens sec.gov)
Dec 54
Corium International, Inc.0001140361-14-044352
SEC(opens sec.gov)
Oct 34
ONYX PHARMACEUTICALS INC0001181431-13-052504
SEC(opens sec.gov)
Jul 24
ONYX PHARMACEUTICALS INC0001179110-13-011353
SEC(opens sec.gov)

Companies

Address

C/O ARYX THERAPEUTICS, INC. 6300 DUMBARTON CIRCLE

FREMONT, CA, 94555